These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 31165654)

  • 1. Developments with multi-target drugs for Alzheimer's disease: an overview of the current discovery approaches.
    González JF; Alcántara AR; Doadrio AL; Sánchez-Montero JM
    Expert Opin Drug Discov; 2019 Sep; 14(9):879-891. PubMed ID: 31165654
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets.
    Uddin MS; Al Mamun A; Kabir MT; Ashraf GM; Bin-Jumah MN; Abdel-Daim MM
    Mol Neurobiol; 2021 Jan; 58(1):281-303. PubMed ID: 32935230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromones: privileged scaffolds for the production of multi-target-directed-ligand agents for the treatment of Alzheimer's disease.
    Silva CFM; Pinto DCGA; Silva AMS
    Expert Opin Drug Discov; 2018 Dec; 13(12):1141-1151. PubMed ID: 30430870
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease.
    Batool A; Kamal MA; Rizvi SMD; Rashid S
    Curr Drug Metab; 2018; 19(8):704-713. PubMed ID: 29512457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular approach in drug development for Alzheimer's disease.
    Agatonovic-Kustrin S; Kettle C; Morton DW
    Biomed Pharmacother; 2018 Oct; 106():553-565. PubMed ID: 29990843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Have there been improvements in Alzheimer's disease drug discovery over the past 5 years?
    Cacabelos R
    Expert Opin Drug Discov; 2018 Jun; 13(6):523-538. PubMed ID: 29607687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target Enzyme in Alzheimer's Disease: Acetylcholinesterase Inhibitors.
    Saxena M; Dubey R
    Curr Top Med Chem; 2019; 19(4):264-275. PubMed ID: 30706815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design.
    Kumar A; Tiwari A; Sharma A
    Curr Neuropharmacol; 2018; 16(6):726-739. PubMed ID: 29542413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer's Disease.
    Iman K; Mirza MU; Mazhar N; Vanmeert M; Irshad I; Kamal MA
    CNS Neurol Disord Drug Targets; 2018 Apr; 17(1):54-68. PubMed ID: 29336270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's Disease, the "One-Molecule, One-Target" Paradigm, and the Multitarget Directed Ligand Approach.
    Oset-Gasque MJ; Marco-Contelles J
    ACS Chem Neurosci; 2018 Mar; 9(3):401-403. PubMed ID: 29465220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).
    Mishra P; Kumar A; Panda G
    Bioorg Med Chem; 2019 Mar; 27(6):895-930. PubMed ID: 30744931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-potent Natural Scaffolds Targeting Amyloid Cascade: In Search of Alzheimer's Disease Therapeutics.
    Chakraborty S
    Curr Top Med Chem; 2017; 17(31):3336-3348. PubMed ID: 29345580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholinesterase inhibitors for the treatment of Alzheimer's disease - a patent review (2016-present).
    Bortolami M; Rocco D; Messore A; Di Santo R; Costi R; Madia VN; Scipione L; Pandolfi F
    Expert Opin Ther Pat; 2021 May; 31(5):399-420. PubMed ID: 33428491
    [No Abstract]   [Full Text] [Related]  

  • 14. Designing Second Generation Anti-Alzheimer Compounds as Inhibitors of Human Acetylcholinesterase: Computational Screening of Synthetic Molecules and Dietary Phytochemicals.
    Amat-Ur-Rasool H; Ahmed M
    PLoS One; 2015; 10(9):e0136509. PubMed ID: 26325402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Old and new acetylcholinesterase inhibitors for Alzheimer's disease.
    Galimberti D; Scarpini E
    Expert Opin Investig Drugs; 2016 Oct; 25(10):1181-7. PubMed ID: 27459153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015).
    McHardy SF; Wang HL; McCowen SV; Valdez MC
    Expert Opin Ther Pat; 2017 Apr; 27(4):455-476. PubMed ID: 27967267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates.
    Dias Viegas FP; de Freitas Silva M; Divino da Rocha M; Castelli MR; Riquiel MM; Machado RP; Vaz SM; Simões de Lima LM; Mancini KC; Marques de Oliveira PC; Morais ÉP; Gontijo VS; da Silva FMR; D'Alincourt da Fonseca Peçanha D; Castro NG; Neves GA; Giusti-Paiva A; Vilela FC; Orlandi L; Camps I; Veloso MP; Leomil Coelho LF; Ionta M; Ferreira-Silva GÁ; Pereira RM; Dardenne LE; Guedes IA; de Oliveira Carneiro Junior W; Quaglio Bellozi PM; Pinheiro de Oliveira AC; Ferreira FF; Pruccoli L; Tarozzi A; Viegas C
    Eur J Med Chem; 2018 Mar; 147():48-65. PubMed ID: 29421570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tea polyphenols as multi-target therapeutics for Alzheimer's disease: An in silico study.
    Mazumder MK; Choudhury S
    Med Hypotheses; 2019 Apr; 125():94-99. PubMed ID: 30902161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of anti-Alzheimer agents: current ligand-based approaches toward the design of acetylcholinesterase inhibitors.
    Speck-Planche A; Luan F; Cordeiro MN
    Mini Rev Med Chem; 2012 Jun; 12(6):583-91. PubMed ID: 22587771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Design of acetylcholinesterase inhibitor for Alzheimer's disease therapy: from multi-binding site inhibitors to multi-target directed ligands].
    Yang WC; Sun Q; Yu NX; Zhu XL; Yang GF
    Yao Xue Xue Bao; 2012 Mar; 47(3):313-21. PubMed ID: 22645754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.